Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/43314

TitleAlbumin-based nanodevices as drug carriers
Author(s)Loureiro, Ana Isabel Sá
Azóia, Nuno G.
Gomes, Andreia C.
Cavaco-Paulo, Artur
KeywordsNanomedicine
albumin
nanoparticles
production methods
specific drug delivery
cancer therapy
Issue date2016
PublisherBentham Science Publishers
JournalCurrent Pharmaceutical Design
CitationLoureiro, Ana; Azoia, Nuno G.; Gomes, Andreia C.; Cavaco-Paulo, Artur, Albumin-based nanodevices as drug carriers. Current Pharmaceutical Design, 22(10), 1371-1390, 2016
Abstract(s)Nanomedicine, the application of nanotechnology to medicine, is being increasingly used to improve and exploit the advantages of efficient drug delivery. Different nanodevices have been developed in recent years, among them protein-based nanoparticles which have gained considerable interest. Albumin is a versatile protein carrier with several characteristics that make it an ideal candidate for drug delivery, such as its availability, its biocompatibility, its biodegradability, and its lack of toxicity and immunogenicity. This review embodies an overview of different methods available for production of albumin-based nanoparticles, with focus on high-energy emulsification methods. A comparison between production by using sonication, which involves acoustic cavitation, and the high pressure homogenization method, where occurs hydrodynamic cavitation, is presented. Taking into account important properties of nanoparticles required for intravenous administration, the use of poloxamers, tri-block copolymer surfactants is discussed as it improves blood circulation time and bioavailability of nanoparticles. Thus, nanoparticles can be engineered to provide adequate features to therapeutic applications, in which can be included surface functionalization with targeting agents. Different albumin-based formulations and their therapeutic applications are presented in this review, with emphasis on applications in cancer therapy, where albumin-based strategies are promising for targeted drug delivery in innovative clinical strategies.
TypeArticle
URIhttp://hdl.handle.net/1822/43314
DOI10.2174/1381612822666160125114900
ISSN1381-6128
Peer-Reviewedyes
AccessRestricted access (Author)
Appears in Collections:CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series

Files in This Item:
File Description SizeFormat 
document_37809_1.pdf
  Restricted access
4,08 MBAdobe PDFView/Open    Request a copy!

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID